Gilead Sciences (GILD)

Gilead's price is at its highest point relative to its recent trend in over a month.

What is going on right now?

Gilead has been climbing steadily, trading about 4% above where it sat just a few weeks ago, with more shares changing hands than usual.

How is the business itself doing?

The company makes antiviral and oncology drugs. It keeps roughly 34 cents of every dollar it earns after operating costs, and its sales grew about 10% over the past year.

What stands out?

Big institutions hold about 92% of its shares, and the stock tends to move very gently compared to the broader market. It barely budges on a typical choppy day.

What comes next?

Gilead reports its next quarterly results on October 29, the first look at whether that 10% sales growth pace is holding.